EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Molecular bacterial detection in nasopharyngeal swabs does not predict the clinical course of lower respiratory tract infections in primary care: an ancillary study of a randomized controlled trial

José Knüsli iD, Loïc Lhopitallier, Andreas Kronenberg, Marc-Antoine Perrenoud, Marie-Anne Page, Aline Mamin, Valérie D'Acremont, Nicolas Senn, Yolanda Mueller, Onya Opota, Isabella Locatelli, Noémie Boillat-Blanco

British Journal of General Practice · 02.11.2026 · BJGP.2026.0056

DOI: 10.3399/bjgp.2026.0056 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of General Practice, online erschienen am 02.11.2026. Verfasst von José Knüsli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lausanne University Hospital, Infectious Diseases Service, Lausanne, Switzerland jose.knusli@chuv.ch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Point-of-care molecular tests on easily collected samples could support antimicrobial stewardship in primary care.

Aim

To determine whether molecular bacterial detection in nasopharyngeal swabs is associated with a worse disease course in patients with lower respiratory tract infections (LRTIs). Design and Setting: Secondary analysis of a randomized controlled trial including 469 consecutive patients with LRTI, from 60 primary care practices in Switzerland.

Methods

Polymerase chain reaction assays for respiratory viruses and bacteria were retrospectively performed on nasopharyngeal swabs. Kaplan-Meier analyses and a multivariate Cox regression were used to evaluate time to recovery according to bacterial detection.

Results

A total of 345 patients were included, of which 142 (41%) had bacteria detected. The detection of bacteria did not influence median time to recovery (7 days in both groups, 95% confidence interval [CI] 6–8 days, p=0.29). Bacterial detection was not associated with time to recovery (adjusted hazard ratio 1.13, 95% CI 0.84–1.50, p=0.42), nor was the interaction term between bacterial detection and antibiotic prescription (adjusted hazard ratio 1.10, 95% CI 0.64–1.90, p=0.74), indicating independence from antibiotic treatment. The detection of bacteria was not associated with a different median duration of cough, sputum, or dyspnoea. The median duration of cough of any severity was 16 days (95% CI 15-18 days).

Conclusion

Among patients with LRTI in primary care, molecular detection of bacteria in nasopharyngeal swabs did not predict a worse disease course. These findings cast doubts on the utility of syndromic molecular testing for managing LRTIs in this setting.

Schlagwörter

Stichwörter der Autor:innen

Infectious illness < Clinical (physical)Prescribing < Clinical (general)Respiratory illness < Clinical (physical)

Autor:innen und Institutionen

  • Lausanne University Hospital, Infectious Diseases Service, Lausanne, Switzerland jose.knusli@chuv.ch.
  • Gare10 Lausanne General Practice, Lausanne, Switzerland.
  • University of Bern, Institute for Infectious Diseases, Bern, Switzerland.
  • Medix General Practice, Bubenbergplatz 8, Bern, Switzerland.
  • Lausanne University Hospital, Microbiology Institute, Lausanne, Switzerland.
  • University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: José Knüsli

Zitieren

APA

Knüsli, J., Lhopitallier, L., Kronenberg, A., Perrenoud, M. A., Page, M. A., Mamin, A., D'Acremont, V., Senn, N., Mueller, Y., Opota, O., Locatelli, I., & Boillat-Blanco, N. (2026). Molecular bacterial detection in nasopharyngeal swabs does not predict the clinical course of lower respiratory tract infections in primary care: an ancillary study of a randomized controlled trial. British Journal of General Practice, BJGP.2026.0056. https://doi.org/10.3399/bjgp.2026.0056

Vancouver

Knüsli J, Lhopitallier L, Kronenberg A, Perrenoud MA, Page MA, Mamin A, et al. Molecular bacterial detection in nasopharyngeal swabs does not predict the clinical course of lower respiratory tract infections in primary care: an ancillary study of a randomized controlled trial. British Journal of General Practice. 2026:BJGP.2026.0056. doi:10.3399/bjgp.2026.0056

BibTeX
@article{Knsli2026,
  author = {Knüsli, José and Lhopitallier, Loïc and Kronenberg, Andreas and Perrenoud, Marc-Antoine and Page, Marie-Anne and Mamin, Aline and D'Acremont, Valérie and Senn, Nicolas and Mueller, Yolanda and Opota, Onya and Locatelli, Isabella and Boillat-Blanco, Noémie},
  title = {Molecular bacterial detection in nasopharyngeal swabs does not predict the clinical course of lower respiratory tract infections in primary care: an ancillary study of a randomized controlled trial},
  journal = {British Journal of General Practice},
  year = {2026},
  pages = {BJGP.2026.0056},
  doi = {10.3399/bjgp.2026.0056}
}
Kostenlos starten →